M3 receptor | Acetylcholine receptors (muscarinic) (2023)

1. Aihara T, Fujishita T, Kanatani K, Furutani K, Nakamura E, Taketo MM, Matsui M, Chen D, Okabe S.(2003)Impaired gastric secretion and lack of trophic responses to hypergastrinemia in M3 muscarinic receptor knockout mice. Gastroenterology, 125 (6): 1774-84. [PMID:14724830]

2. Aihara T, Nakamura Y, Taketo MM, Matsui M, Okabe S.(2005)Cholinergically stimulated gastric acid secretion is mediated by M(3) and M(5) but not M(1) muscarinic acetylcholine receptors in mice. Am J Physiol Gastrointest Liver Physiol, 288 (6): G1199-207. [PMID:15691866]

3. Auerbach SS, DrugMatrix® and ToxFX® Coordinator National Toxicology Program.National Toxicology Program: Dept of Health and Human Services. Accessed on 02/05/2014. Modified on 02/05/2014. DrugMatrix,https://ntp.niehs.nih.gov/drugmatrix/index.html

4. Baghdoyan HA.(1997)Location and quantification of muscarinic receptor subtypes in rat pons: implications for REM sleep generation. Am J Physiol, 273 (3 Pt 2): R896-904. [PMID:9321865]

5. Birdsall NJ, Farries T, Gharagozloo P, Kobayashi S, Lazareno S, Sugimoto M.(1999)Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies. Mol Pharmacol, 55 (4): 778-86. [PMID:10101037]

6. Bolden C, Cusack B, Richelson E.(1992)Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther, 260 (2): 576-80. [PMID:1346637]

7. Boudinot E, Yamada M, Wess J, Champagnat J, Foutz AS.(2004)Ventilatory pattern and chemosensitivity in M1 and M3 muscarinic receptor knockout mice. Respir Physiol Neurobiol, 139 (3): 237-45. [PMID:15122990]

8. Bridges TM, Marlo JE, Niswender CM, Jones CK, Jadhav SB, Gentry PR, Plumley HC, Weaver CD, Conn PJ, Lindsley CW.(2009)Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins. J Med Chem, 52 (11): 3445-8. [PMID:19438238]

9. Bräuner-Osborne H, Brann MR.(1996)Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): high throughput assays in mammalian cells. Eur J Pharmacol, 295 (1): 93-102. [PMID:8925880]

10. Bräuner-Osborne H, Ebert B, Brann MR, Falch E, Krogsgaard-Larsen P.(1996)Functional partial agonism at cloned human muscarinic acetylcholine receptors. Eur J Pharmacol, 313 (1-2): 145-50. [PMID:8905341]

11. Buckley NJ, Bonner TI, Buckley CM, Brann MR.(1989)Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol, 35 (4): 469-76. [PMID:2704370]

12. Budd DC, Rae A, Tobin AB.(1999)Activation of the mitogen-activated protein kinase pathway by a Gq/11-coupled muscarinic receptor is independent of receptor internalization. J Biol Chem, 274 (18): 12355-60. [PMID:10212206]

13. Bymaster FP, McKinzie DL, Felder CC, Wess J.(2003)Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochem Res, 28 (3-4): 437-42. [PMID:12675128]

14. Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G.(2003)Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists. J Med Chem, 46 (5): 856-67. [PMID:12593665]

15. Candell LM, Yun SH, Tran LL, Ehlert FJ.(1990)Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum. Mol Pharmacol, 38 (5): 689-97. [PMID:2172776]

16. Carzaniga L, Linney ID, Rizzi A, Delcanale M, Schmidt W, Knight CK, Pastore F, Miglietta D, Carnini C, Cesari N et al..(2022)Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases. J Med Chem, 65 (15): 10233-10250. [PMID:35901125]

17. Cembala TM, Sherwin JD, Tidmarsh MD, Appadu BL, Lambert DG.(1998)Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. Br J Pharmacol, 125 (5): 1088-94. [PMID:9846649]

18. Ch'ng SS, Walker AJ, McCarthy M, Le TK, Thomas N, Gibbons A, Udawela M, Kusljic S, Dean B, Gogos A.(2020)The Impact of Removal of Ovarian Hormones on Cholinergic Muscarinic Receptors: Examining Prepulse Inhibition and Receptor Binding. Brain Sci, 10 (2). [PMID:32079174]

19. Cheng K, Khurana S, Chen Y, Kennedy RH, Zimniak P, Raufman JP.(2002)Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist. J Pharmacol Exp Ther, 303 (1): 29-35. [PMID:12235229]

20. Christopoulos A, Grant MK, Ayoubzadeh N, Kim ON, Sauerberg P, Jeppesen L, El-Fakahany EE.(2001)Synthesis and pharmacological evaluation of dimeric muscarinic acetylcholine receptor agonists. J Pharmacol Exp Ther, 298 (3): 1260-8. [PMID:11504829]

21. Croy CH, Chan WY, Castetter AM, Watt ML, Quets AT, Felder CC.(2016)Characterization of PCS1055, a novel muscarinic M4 receptor antagonist. Eur J Pharmacol, 782: 70-6. [PMID:27085897]

22. D'Agostino G, Bolognesi ML, Lucchelli A, Vicini D, Balestra B, Spelta V, Melchiorre C, Tonini M.(2000)Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype. Br J Pharmacol, 129 (3): 493-500. [PMID:10711347]

23. Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M et al..(2012)1,4-dioxane, a suitable scaffold for the development of novel M₃ muscarinic receptor antagonists. J Med Chem, 55 (4): 1783-7. [PMID:22243489]

24. Disse B, Reichl R, Speck G, Traunecker W, Ludwig Rominger KL, Hammer R.(1993)Ba 679 BR, a novel long-acting anticholinergic bronchodilator. Life Sci, 52 (5-6): 537-44. [PMID:8441333]

25. Dowling MR, Charlton SJ.(2006)Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor. Br J Pharmacol, 148 (7): 927-37. [PMID:16847442]

26. Duttaroy A, Zimliki CL, Gautam D, Cui Y, Mears D, Wess J.(2004)Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Diabetes, 53 (7): 1714-20. [PMID:15220195]

27. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR.(1991)Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther, 256 (2): 727-33. [PMID:1994002]

28. Ehlert FJ, Griffin MT, Abe DM, Vo TH, Taketo MM, Manabe T, Matsui M.(2005)The M2 muscarinic receptor mediates contraction through indirect mechanisms in mouse urinary bladder. J Pharmacol Exp Ther, 313 (1): 368-78. [PMID:15608083]

29. Ehlert FJ, Griffin MT, Glidden PF.(1996)The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor. J Pharmacol Exp Ther, 279 (3): 1335-44. [PMID:8968358]

30. Ehlert FJ, Griffin MT, Sawyer GW, Bailon R.(1999)A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells. J Pharmacol Exp Ther, 289 (2): 981-92. [PMID:10215678]

31. Esqueda EE, Gerstin Jr EH, Griffin MT, Ehlert FJ.(1996)Stimulation of cyclic AMP accumulation and phosphoinositide hydrolysis by M3 muscarinic receptors in the rat peripheral lung. Biochem Pharmacol, 52 (4): 643-58. [PMID:8759038]

32. Fisher JT, Vincent SG, Gomeza J, Yamada M, Wess J.(2004)Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. FASEB J, 18 (6): 711-3. [PMID:14977875]

33. Forsythe SM, Kogut PC, McConville JF, Fu Y, McCauley JA, Halayko AJ, Liu HW, Kao A, Fernandes DJ, Bellam S et al..(2002)Structure and transcription of the human m3 muscarinic receptor gene. Am J Respir Cell Mol Biol, 26 (3): 298-305. [PMID:11867338]

34. Gautam D, Gavrilova O, Jeon J, Pack S, Jou W, Cui Y, Li JH, Wess J.(2006)Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. Cell Metab, 4 (5): 363-75. [PMID:17084710]

35. Gautam D, Han SJ, Hamdan FF, Jeon J, Li B, Li JH, Cui Y, Mears D, Lu H, Deng C et al..(2006)A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab, 3 (6): 449-61. [PMID:16753580]

36. Gentry PR, Kokubo M, Bridges TM, Cho HP, Smith E, Chase P, Hodder PS, Utley TJ, Rajapakse A, Byers F et al..(2014)Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe. ChemMedChem, 9 (8): 1677-82. [PMID:24692176]

37. Gillberg PG, Sundquist S, Nilvebrant L.(1998)Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists. Eur J Pharmacol, 349 (2-3): 285-92. [PMID:9671109]

38. Goutagny R, Comte JC, Salvert D, Gomeza J, Yamada M, Wess J, Luppi PH, Fort P.(2005)Paradoxical sleep in mice lacking M3 and M2/M4 muscarinic receptors. Neuropsychobiology, 52 (3): 140-6. [PMID:16110248]

39. Grillner P, Bonci A, Svensson TH, Bernardi G, Mercuri NB.(1999)Presynaptic muscarinic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon. Neuroscience, 91 (2): 557-65. [PMID:10366013]

40. Hassall CJ, Stanford SC, Burnstock G, Buckley NJ.(1993)Co-expression of four muscarinic receptor genes by the intrinsic neurons of the rat and guinea-pig heart. Neuroscience, 56 (4): 1041-8. [PMID:8284034]

41. Hegde SS, Choppin A, Bonhaus D, Briaud S, Loeb M, Moy TM, Loury D, Eglen RM.(1997)Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br J Pharmacol, 120 (8): 1409-18. [PMID:9113359]

42. Hegde SS, Pulido-Rios MT, Luttmann MA, Foley JJ, Hunsberger GE, Steinfeld T, Lee T, Ji Y, Mammen MM, Jasper JR.(2018)Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues. Pharmacol Res Perspect, 6 (3): e00400. [PMID:29736245]

43. Hirose H, Aoki I, Kimura T, Fujikawa T, Numazawa T, Sasaki K, Sato A, Hasegawa T, Nishikibe M, Mitsuya M et al..(2001)Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity. J Pharmacol Exp Ther, 297 (2): 790-7. [PMID:11303071]

44. Huang F, Buchwald P, Browne CE, Farag HH, Wu WM, Ji F, Hochhaus G, Bodor N.(2001)Receptor binding studies of soft anticholinergic agents. AAPS PharmSci, 3 (4): E30. [PMID:12049493]

45. Ikeda K, Kobayashi S, Suzuki M, Miyata K, Takeuchi M, Yamada T, Honda K.(2002)M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Naunyn Schmiedebergs Arch Pharmacol, 366 (2): 97-103. [PMID:12122494]

46. Jakubík J, Bacáková L, el-Fakahany EE, Tucek S.(1995)Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. J Pharmacol Exp Ther, 274 (3): 1077-83. [PMID:7562472]

47. Jakubík J, Bacáková L, El-Fakahany EE, Tucek S.(1997)Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol Pharmacol, 52 (1): 172-9. [PMID:9224827]

48. Jeon WJ, Gibbons AS, Dean B.(2013)The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders. Prog Neuropsychopharmacol Biol Psychiatry, 47: 7-12. [PMID:23962466]

49. Jolkkonen M, van Giersbergen PL, Hellman U, Wernstedt C, Karlsson E.(1994)A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett, 352 (1): 91-4. [PMID:7925952]

50. Kashihara K, Varga EV, Waite SL, Roeske WR, Yamamura HI.(1992)Cloning of the rat M3, M4 and M5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterization of the expressed genes. Life Sci, 51 (12): 955-71. [PMID:1325587]

51. Keov P, Valant C, Devine SM, Lane JR, Scammells PJ, Sexton PM, Christopoulos A.(2013)Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor. Mol Pharmacol, 84 (3): 425-37. [PMID:23798605]

52. Khattar SK, Bora RS, Priyadarsiny P, Gupta D, Khanna A, Narayanan KL, Babu V, Chugh A, Saini KS.(2006)High level stable expression of pharmacologically active human M1-M5 muscarinic receptor subtypes in mammalian cells. Biotechnol Lett, 28 (2): 121-9. [PMID:16369696]

53. Khurana S, Yamada M, Wess J, Kennedy RH, Raufman JP.(2005)Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent. Eur J Pharmacol, 517 (1-2): 103-10. [PMID:15964566]

54. Kim JY, Yang MS, Oh CD, Kim KT, Ha MJ, Kang SS, Chun JS.(1999)Signalling pathway leading to an activation of mitogen-activated protein kinase by stimulating M3 muscarinic receptor. Biochem J, 337 ( Pt 2): 275-80. [PMID:9882625]

55. Kono M, Nakamura Y, Ishiura Y, Komatsu K, Kontani H, Namiki M.(2006)Central muscarinic receptor subtypes regulating voiding in rats. J Urol, 175 (1): 353-7. [PMID:16406941]

56. Kruse AC, Hu J, Pan AC, Arlow DH, Rosenbaum DM, Rosemond E, Green HF, Liu T, Chae PS, Dror RO et al..(2012)Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature, 482 (7386): 552-6. [PMID:22358844]

57. Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ et al..(2009)Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists. J Med Chem, 52 (8): 2493-505. [PMID:19317446]

58. Lamping KG, Wess J, Cui Y, Nuno DW, Faraci FM.(2004)Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine. Arterioscler Thromb Vasc Biol, 24: 1253-1258. [PMID:15130910]

59. Lazareno S, Birdsall NJ.(1993)Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies. Br J Pharmacol, 109 (4): 1120-7. [PMID:8401923]

60. Lazareno S, Birdsall NJ.(1995)Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol, 48 (2): 362-78. [PMID:7651370]

61. Lazareno S, Dolezal V, Popham A, Birdsall NJ.(2004)Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Mol Pharmacol, 65 (1): 257-66. [PMID:14722259]

62. Lazareno S, Farries T, Birdsall NJ.(1993)Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4. Life Sci, 52 (5-6): 449-56. [PMID:8441327]

63. Lazareno S, Gharagozloo P, Kuonen D, Popham A, Birdsall NJ.(1998)Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies. Mol Pharmacol, 53 (3): 573-89. [PMID:9495826]

64. Lazareno S, Popham A, Birdsall NJ.(2000)Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site. Mol Pharmacol, 58 (1): 194-207. [PMID:10860942]

65. Lazareno S, Popham A, Birdsall NJ.(2002)Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors. Mol Pharmacol, 62 (6): 1492-505. [PMID:12435818]

66. Levey AI, Edmunds SM, Heilman CJ, Desmond TJ, Frey KA.(1994)Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain. Neuroscience, 63 (1): 207-21. [PMID:7898649]

67. Levey AI, Edmunds SM, Koliatsos V, Wiley RG, Heilman CJ.(1995)Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J Neurosci, 15 (5 Pt 2): 4077-92. [PMID:7751967]

68. Lin S, Kajimura M, Takeuchi K, Kodaira M, Hanai H, Kaneko E.(1997)Expression of muscarinic receptor subtypes in rat gastric smooth muscle: effect of M3 selective antagonist on gastric motility and emptying. Dig Dis Sci, 42 (5): 907-14. [PMID:9149041]

69. Loudon JM, Bromidge SM, Brown F, Clark MS, Hatcher JP, Hawkins J, Riley GJ, Noy G, Orlek BS.(1997)SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors. J Pharmacol Exp Ther, 283 (3): 1059-68. [PMID:9399977]

70. Mak JC, Barnes PJ.(1989)Muscarinic receptor subtypes in human and guinea pig lung. Eur J Pharmacol, 164 (2): 223-30. [PMID:2759174]

71. Matsui M, Araki Y, Karasawa H, Matsubara N, Taketo MM, Seldin MF.(1999)Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes. Genes Genet Syst, 74 (1): 15-21. [PMID:10549128]

72. Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, Takahashi S, Taketo MM.(2000)Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA, 97 (17): 9579-84. [PMID:10944224]

73. Matsui M, Yamada S, Oki T, Manabe T, Taketo MM, Ehlert FJ.(2004)Functional analysis of muscarinic acetylcholine receptors using knockout mice. Life Sci, 75 (25): 2971-81. [PMID:15474550]

74. McCormack DG, Mak JC, Minette P, Barnes PJ.(1988)Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery. Eur J Pharmacol, 158 (3): 293-7. [PMID:3253104]

75. Miller JH, Aagaard PJ, Gibson VA, McKinney M.(1992)Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors. J Pharmacol Exp Ther, 263 (2): 663-7. [PMID:1331410]

76. Minarini A, Marucci G, Bellucci C, Giorgi G, Tumiatti V, Bolognesi ML, Matera R, Rosini M, Melchiorre C.(2008)Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics. Bioorg Med Chem, 16 (15): 7311-20. [PMID:18595721]

77. Nakamura T, Matsui M, Uchida K, Futatsugi A, Kusakawa S, Matsumoto N, Nakamura K, Manabe T, Taketo MM, Mikoshiba K.(2004)M(3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice. J Physiol (Lond.), 558 (Pt 2): 561-75. [PMID:15146045]

78. Näsman J, Jolkkonen M, Ammoun S, Karlsson E, Akerman KE.(2000)Recombinant expression of a selective blocker of M(1) muscarinic receptors. Biochem Biophys Res Commun, 271 (2): 435-9. [PMID:10799315]

79. Oki T, Takagi Y, Inagaki S, Taketo MM, Manabe T, Matsui M, Yamada S.(2005)Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice. Brain Res Mol Brain Res, 133 (1): 6-11. [PMID:15661360]

80. Olianas MC, Ingianni A, Maullu C, Adem A, Karlsson E, Onali P.(1999)Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors. J Pharmacol Exp Ther, 288 (1): 164-70. [PMID:9862767]

81. Orman B, Sterin-Borda L, Reina S, Borda ES.(2005)Neuronal nitric oxide synthase activity in rat urinary bladder detrusor: participation in M3 and M4 muscarinic receptor function. Auton Autacoid Pharmacol, 25 (3): 93-100. [PMID:15955028]

82. Ozenil M, Pacher K, Balber T, Vraka C, Roller A, Holzer W, Spreitzer H, Mitterhauser M, Wadsak W, Hacker M et al..(2020)Enhanced arecoline derivatives as muscarinic acetylcholine receptor M1 ligands for potential application as PET radiotracers. Eur J Med Chem, 204: 112623. [PMID:32717485]

83. Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW.(1998)6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors. J Med Chem, 41 (12): 2047-55. [PMID:9622546]

84. Peralta EG, Ashkenazi A, Winslow JW, Ramachandran J, Capon DJ.(1988)Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature, 334 (6181): 434-7. [PMID:2841607]

85. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ.(1987)Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J, 6 (13): 3923-9. [PMID:3443095]

86. Pfeiffer A, Rochlitz H, Noelke B, Tacke R, Moser U, Mutschler E, Lambrecht G.(1990)Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of M3 type. Gastroenterology, 98 (1): 218-22. [PMID:2293581]

87. Post MJ, Te Biesebeek JD, Doods HN, Wemer J, Van Rooji HH, Porsius AJ.(1991)Functional characterization of the muscarinic receptor in rat lungs. Eur J Pharmacol, 202 (1): 67-72. [PMID:1723953]

88. Powers AS, Pham V, Burger WAC, Thompson G, Laloudakis Y, Sexton PM, Paul SM, Christopoulos A, Thal DM, Felder CC et al..(2023)Structural basis of efficacy-driven ligand selectivity at GPCRs. Nat Chem Biol, [Epub ahead of print]. [PMID:36782010]

89. Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S et al..(2011)Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists. Bioorg Med Chem Lett, 21 (11): 3457-61. [PMID:21524581]

90. Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A et al..(2009)Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide). J Med Chem, 52 (16): 5076-92. [PMID:19653626]

91. Preiksaitis HG, Krysiak PS, Chrones T, Rajgopal V, Laurier LG.(2000)Pharmacological and molecular characterization of muscarinic receptor subtypes in human esophageal smooth muscle. J Pharmacol Exp Ther, 295 (3): 879-88. [PMID:11082420]

92. Pönicke K, Heinroth-Hoffmann I, Brodde OE.(2003)Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats. Br J Pharmacol, 138 (1): 156-60. [PMID:12522085]

93. Renuka TR, Robinson R, Paulose CS.(2006)Increased insulin secretion by muscarinic M1 and M3 receptor function from rat pancreatic islets in vitro. Neurochem Res, 31 (3): 313-20. [PMID:16733808]

94. Richards MH, van Giersbergen PL.(1995)Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists. Br J Pharmacol, 114 (6): 1241-9. [PMID:7620715]

95. Rosenblum K, Futter M, Jones M, Hulme EC, Bliss TV.(2000)ERKI/II regulation by the muscarinic acetylcholine receptors in neurons. J Neurosci, 20 (3): 977-85. [PMID:10648702]

96. Salmon M, Luttmann MA, Foley JJ, Buckley PT, Schmidt DB, Burman M, Webb EF, DeHaas CJ, Kotzer CJ, Barrett VJ et al..(2013)Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases. J Pharmacol Exp Ther, 345 (2): 260-70. [PMID:23435542]

97. Schrage R, Holze J, Klöckner J, Balkow A, Klause AS, Schmitz AL, De Amici M, Kostenis E, Tränkle C, Holzgrabe U et al..(2014)New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo. Biochem Pharmacol, 90 (3): 307-19. [PMID:24863257]

98. Sheffler DJ, Williams R, Bridges TM, Xiang Z, Kane AS, Byun NE, Jadhav S, Mock MM, Zheng F, Lewis LM et al..(2009)A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning. Mol Pharmacol, 76 (2): 356-68. [PMID:19407080]

99. Shida T, Tokunaga A, Kondo E, Ueda Y, Ohno K, Saika T, Kiyama H, Tohyama M.(1993)Expression of muscarinic and nicotinic receptor mRNA in the salivary gland of rats: a study by in situ hybridization histochemistry. Brain Res Mol Brain Res, 17 (3-4): 335-9. [PMID:8510505]

100. Sinha S, Gupta S, Malhotra S, Krishna NS, Meru AV, Babu V, Bansal V, Garg M, Kumar N, Chugh A et al..(2010)AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder. Br J Pharmacol, 160 (5): 1119-27. [PMID:20590605]

101. Smith CM, Wallis RM.(1997)Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors. J Recept Signal Transduct Res, 17 (1-3): 177-84. [PMID:9029489]

102. Stanton T, Bolden-Watson C, Cusack B, Richelson E.(1993)Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics. Biochem Pharmacol, 45 (11): 2352-4. [PMID:8100134]

103. Stengel PW, Cohen ML.(2002)Muscarinic receptor knockout mice: role of muscarinic acetylcholine receptors M(2), M(3), and M(4) in carbamylcholine-induced gallbladder contractility. J Pharmacol Exp Ther, 301 (2): 643-50. [PMID:11961069]

104. Stengel PW, Yamada M, Wess J, Cohen ML.(2002)M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol, 282 (5): R1443-9. [PMID:11959688]

105. Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J et al..(2010)The discovery of new spirocyclic muscarinic M3 antagonists. Bioorg Med Chem Lett, 20 (24): 7458-61. [PMID:21036043]

106. Struckmann N, Schwering S, Wiegand S, Gschnell A, Yamada M, Kummer W, Wess J, Haberberger RV.(2003)Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice. Mol Pharmacol, 64 (6): 1444-51. [PMID:14645675]

107. Sykes DA, Dowling MR, Leighton-Davies J, Kent TC, Fawcett L, Renard E, Trifilieff A, Charlton SJ.(2012)The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium. J Pharmacol Exp Ther, 343 (2): 520-8. [PMID:22854200]

108. Tanis SP, Plewe MB, Johnson TW, Butler SL, Dalvie D, DeLisle D, Dress KR, Hu Q, Huang B, Kuehler JE et al..(2010)Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK. Bioorg Med Chem Lett, 20 (24): 7429-34. [PMID:21036042]

109. Tobin G, Giglio D, Götrick B.(2002)Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats. Auton Neurosci, 100 (1-2): 1-9. [PMID:12422954]

110. Tseng J, Erbe CB, Kwitek AE, Jacob HJ, Popper P, Wackym PA.(2002)Radiation hybrid mapping of five muscarinic acetylcholine receptor subtype genes in Rattus norvegicus. Hear Res, 174 (1-2): 86-92. [PMID:12433399]

111. Tyagi S, Tyagi P, Van-le S, Yoshimura N, Chancellor MB, de Miguel F.(2006)Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor. J Urol, 176 (4 Pt 1): 1673-8. [PMID:16952712]

112. Vilaró MT, Palacios JM, Mengod G.(1994)Multiplicity of muscarinic autoreceptor subtypes? Comparison of the distribution of cholinergic cells and cells containing mRNA for five subtypes of muscarinic receptors in the rat brain. Brain Res Mol Brain Res, 21 (1-2): 30-46. [PMID:8164520]

113. Wackym PA, Chen CT, Ishiyama A, Pettis RM, López IA, Hoffman L.(1996)Muscarinic acetylcholine receptor subtype mRNAs in the human and rat vestibular periphery. Cell Biol Int, 20 (3): 187-92. [PMID:8673067]

114. Waelbroeck M, De Neef P, Domenach V, Vandermeers-Piret MC, Vandermeers A.(1996)Binding of the labelled muscarinic toxin 125I-MT1 to rat brain muscarinic M1 receptors. Eur J Pharmacol, 305 (1-3): 187-92. [PMID:8813552]

115. Wang SZ, el-Fakahany EE.(1993)Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists. J Pharmacol Exp Ther, 266 (1): 237-43. [PMID:7687290]

116. Wang SZ, Lee SY, Zhu SZ, el-Fakahany EE.(1996)Differential coupling of m1, m3, and m5 muscarinic receptors to activation of neuronal nitric oxide synthase. Pharmacology, 53 (5): 271-80. [PMID:8990485]

117. Watson J, Brough S, Coldwell MC, Gager T, Ho M, Hunter AJ, Jerman J, Middlemiss DN, Riley GJ, Brown AM.(1998)Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors. Br J Pharmacol, 125 (7): 1413-20. [PMID:9884068]

118. Watson N, Daniels DV, Ford AP, Eglen RM, Hegde SS.(1999)Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells. Br J Pharmacol, 127 (2): 590-6. [PMID:10385263]

119. Weber S, Thiele H, Mir S, Toliat MR, Sozeri B, Reutter H, Draaken M, Ludwig M, Altmüller J, Frommolt P et al..(2011)Muscarinic Acetylcholine Receptor M3 Mutation Causes Urinary Bladder Disease and a Prune-Belly-like Syndrome. Am J Hum Genet, 89 (5): 668-74. [PMID:22077972]

120. Wess J.(2003)Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends Pharmacol Sci, 24 (8): 414-20. [PMID:12915051]

121. Wess J.(2004)Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol, 44: 423-50. [PMID:14744253]

122. Wess J, Duttaroy A, Zhang W, Gomeza J, Cui Y, Miyakawa T, Bymaster FP, McKinzie L, Felder CC, Lamping KG et al..(2003)M1-M5 muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system. Recept Channels, 9 (4): 279-90. [PMID:12893539]

123. Wess J, Lambrecht G, Mutschler E, Brann MR, Dörje F.(1991)Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations. Br J Pharmacol, 102 (1): 246-50. [PMID:2043926]

124. Widzowski DV, Bialobok P, Kucera KE, Mihut R, Sitar S, Knowles M, Stagnitto M, Howell A, McCreedy S, Machulskis A, Gordon J, Marler M, Wu ESC, Mullen G, Triggle DJ, Blosser J.(1997)Development of a pharmacological target profile for muscarinic agonists. Drug Development Research, 40: 117-132.

125. Willmy-Matthes P, Leineweber K, Wangemann T, Silber RE, Brodde OE.(2003)Existence of functional M3-muscarinic receptors in the human heart. Naunyn Schmiedebergs Arch Pharmacol, 368 (4): 316-9. [PMID:14520506]

126. Wood MD, Murkitt KL, Ho M, Watson JM, Brown F, Hunter AJ, Middlemiss DN.(1999)Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry. Br J Pharmacol, 126 (7): 1620-4. [PMID:10323594]

127. Xie G, Drachenberg C, Yamada M, Wess J, Raufman JP.(2005)Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors. Am J Physiol Gastrointest Liver Physiol, 289 (3): G521-9. [PMID:15933222]

128. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN et al..(2001)Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature, 410 (6825): 207-12. [PMID:11242080]

129. Yamashita Y, Tanaka K, Asano T, Yamakawa N, Kobayashi D, Ishihara T, Hanaya K, Shoji M, Sugai T, Wada M et al..(2014)Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities. Bioorg Med Chem, 22 (13): 3488-97. [PMID:24844758]

130. Yasuda RP, Ciesla W, Flores LR, Wall SJ, Li M, Satkus SA, Weisstein JS, Spagnola BV, Wolfe BB.(1993)Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Mol Pharmacol, 43 (2): 149-57. [PMID:8429821]

131. Zawalich WS, Zawalich KC, Tesz GJ, Taketo MM, Sterpka J, Philbrick W, Matsui M.(2004)Effects of muscarinic receptor type 3 knockout on mouse islet secretory responses. Biochem Biophys Res Commun, 315 (4): 872-6. [PMID:14985093]

132. Zhang W, Yamada M, Gomeza J, Basile AS, Wess J.(2002)Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. J Neurosci, 22 (15): 6347-52. [PMID:12151512]

133. Zhang X, Hernandez MR, Yang H, Erickson K.(1995)Expression of muscarinic receptor subtype mRNA in the human ciliary muscle. Invest Ophthalmol Vis Sci, 36 (8): 1645-57. [PMID:7541396]


Top Articles
Latest Posts
Article information

Author: Mr. See Jast

Last Updated: 26/10/2023

Views: 5920

Rating: 4.4 / 5 (75 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Mr. See Jast

Birthday: 1999-07-30

Address: 8409 Megan Mountain, New Mathew, MT 44997-8193

Phone: +5023589614038

Job: Chief Executive

Hobby: Leather crafting, Flag Football, Candle making, Flying, Poi, Gunsmithing, Swimming

Introduction: My name is Mr. See Jast, I am a open, jolly, gorgeous, courageous, inexpensive, friendly, homely person who loves writing and wants to share my knowledge and understanding with you.